Successful management of COVID‐19 and associated coagulopathy in a patient with durable left ventricular assist device | Zendy

Hodges Kevin | Zendy; Mubashir Mujtaba | Zendy; Insler Joshua | Zendy; Estep Jerry | Zendy; Hsich Eileen | Zendy; Tong Michael | Zendy; Insler Steven | Zendy; Soltesz Edward | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Premium

Successful management of COVID‐19 and associated coagulopathy in a patient with durable left ventricular assist device

Author(s) -

Hodges Kevin,

Mubashir Mujtaba,

Insler Joshua,

Estep Jerry,

Hsich Eileen,

Tong Michael,

Insler Steven,

Soltesz Edward

Publication year - 2020

Publication title -

journal of cardiac surgery

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.428

H-Index - 58

eISSN - 1540-8191

pISSN - 0886-0440

DOI - 10.1111/jocs.14937

Subject(s) - medicine , coagulopathy , covid-19 , cytokine storm , intensive care medicine , multidisciplinary approach , ventricular assist device , cardiology , heart failure , pathology , infectious disease (medical specialty) , disease , outbreak , social science , sociology

Patients with durable left ventricular assist devices pose special problems for management in the setting of COVID‐19 infection. We describe the successful management of a 44‐year‐old man with severe COVID‐19 infection and HeartMate 3 left ventricular assist device. His course was complicated by cytokine storm and COVID‐19‐associated coagulopathy. We describe our institutional protocol for managing COVID‐19 infection in patients on mechanical circulatory support, focusing on the need for a thoughtful, multidisciplinary approach.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here

Accelerating Research